Comments: LA HB403 | 2023 | Regular Session
Bill Title: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Text: Latest bill text (Chaptered) [PDF]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2023 Louisiana HB403 at this time. |